Literature DB >> 17161192

Is contralateral exploration necessary in preterm infants with unilateral inguinal hernia?

Mohan Marulaiah1, John Atkinson, Askar Kukkady, Stuart Brown, Udaya Samarakkody.   

Abstract

PURPOSE: Contralateral inguinal exploration has been the preferred approach to preterm infants with unilateral inguinal hernia. There is no literature evidence to justify this. The aim of this prospective study is to analyze the incidence and to determine any risk factors for the development of contralateral metachronous hernia (MH) in the preterm when compared with term infants.
METHODS: Preterm and term infants with unilateral inguinal hernia younger than 6 months who underwent surgery were included. Those infants who subsequently developed MH were analyzed.
RESULTS: Two hundred sixty-six patients met the inclusion criteria. One hundred five were preterm and 161 were term. Ten preterm (10.31%) and 9 term infants (5.92%) presented subsequently with MH (P =.18). All but 1 were male. There was no relation between the side of hernia, presentation with incarceration, age at surgery, sex of the patient, and the development of MH. However, a trend toward a higher incidence of MH in very low birth weight and early gestational age preterms was noted.
CONCLUSION: There is no significant difference between the occurrence of MH in preterm when compared with term infants. Routine contralateral exploration in preterm infants with its associated risks is therefore not justified in unilateral hernia.

Entities:  

Mesh:

Year:  2006        PMID: 17161192     DOI: 10.1016/j.jpedsurg.2006.08.026

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Contralateral inguinal exploration in premature neonates: is it necessary?

Authors:  Mairi Steven; Owen Greene; Adam Nelson; Nicola Brindley
Journal:  Pediatr Surg Int       Date:  2010-05-08       Impact factor: 1.827

Review 2.  Physical deformities relevant to male infertility.

Authors:  Rajender Singh; Alaa J Hamada; Laura Bukavina; Ashok Agarwal
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 3.  Systematic review for paediatric metachronous contralateral inguinal hernia: a decreasing concern.

Authors:  Ramesh M Nataraja; Anies A Mahomed
Journal:  Pediatr Surg Int       Date:  2011-05-21       Impact factor: 1.827

4.  Inguinal hernia in neonates and ex-preterm: complications, timing and need for routine contralateral exploration.

Authors:  A Pini Prato; V Rossi; M Mosconi; N Disma; L Mameli; G Montobbio; A Michelazzi; F Faranda; S Avanzini; P Buffa; L Ramenghi; P Tuo; G Mattioli
Journal:  Pediatr Surg Int       Date:  2014-11-09       Impact factor: 1.827

5.  Predictors of metachronous inguinal hernias in children.

Authors:  Mohammed Zamakhshardy; Arlene Ein; Sigmund H Ein; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2008-11-07       Impact factor: 1.827

Review 6.  Pediatric inguinal hernia repair-a critical appraisal.

Authors:  J Rosenberg
Journal:  Hernia       Date:  2007-11-30       Impact factor: 4.739

7.  Contralateral exploration for unilateral inguinal hernia in females: risk factors and surgical findings.

Authors:  N Zampieri; V Zuin; A Ottolenghi; F S Camoglio
Journal:  Hernia       Date:  2008-05-22       Impact factor: 4.739

8.  Controversies regarding neonatal inguinal hernia.

Authors:  V Raveenthiran
Journal:  J Neonatal Surg       Date:  2014-07-10

9.  Management of inguinal hernia in premature infants: 10-year experience.

Authors:  Stanley John Crankson; Khalil Al Tawil; Mohammad Al Namshan; Saud Al Jadaan; Beverly Jane Baylon; Mutaz Gieballa; Ibrahim Hakim Ahmed
Journal:  J Indian Assoc Pediatr Surg       Date:  2015-01

10.  Learning Curves for Laparoscopic Repair of Inguinal Hernia and Communicating Hydrocele in Children.

Authors:  Catarina Barroso; Péter Etlinger; Ana Luísa Alves; Angélica Osório; José Luís Carvalho; Ruben Lamas-Pinheiro; Jorge Correia-Pinto
Journal:  Front Pediatr       Date:  2017-09-27       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.